- Presentations
- 3
- Markets
- 1
Rybelsus is a brand of Semaglutide marketed by Novo Nordisk Pharmaceutical Industries, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Semaglutide
- Brand owner
- Novo Nordisk Pharmaceutical Industries
- Registered in
- United States
- Strengths and forms
- 14 mg tablet, 3 mg tablet, 7 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Rybelsus 14 mg tabletOral | Novo Nordisk Pharmaceutical Industries | US FDA | Available on request |
| Rybelsus 3 mg tabletOral | Novo Nordisk Pharmaceutical Industries | US FDA | Available on request |
| Rybelsus 7 mg tabletOral | Novo Nordisk Pharmaceutical Industries | US FDA | Available on request |
Equivalent brands
Other brands of Semaglutide.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Rybelsus
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.